Diabetic Kidney Disease

Metabolic·MeSH: Diabetic Nephropathies

6 drugs in development·4 companies·6 clinical trials

Drug Pipeline by Phase

Phase 2(6)

Drug	Company
2hpβcd	ZyVersa Therapeutics, Inc. (ZVSA)
aln-ang3	West Pharmaceutical Services Inc. (WST)
aln-ang3	REGENERON PHARMACEUTICALS, INC. (REGN)
evinacumab	REGENERON PHARMACEUTICALS, INC. (REGN)
evinacumab	West Pharmaceutical Services Inc. (WST)
renal autologous cell therapy	PROKIDNEY CORP. (PROK)

BioSniper tracks 6 drugs in development for Diabetic Kidney Disease across 4 companies.

There are 6 clinical trials targeting Diabetic Kidney Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.